Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI

Brain

Volumn 129, Issue 9, 2006, Pages 2384-2393

  Wu, Ona ^a,b   Christensen, Søren ^a   Hjort, Niels ^a   Dijkhuizen, Rick M ^b   Kucinski, Thomas ^c   Fiehler, Jens ^c   Thomalla, Götz ^c   Röther, Joachim ^c   Østergaard, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cerebral ischaemia; Magnetic resonance imaging; Mathematical modelling; Outcome measures; Thrombolytic therapy

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MATHEMATICAL MODEL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL MODEL; VOLUMETRY; ACUTE DISEASE; ALGORITHM; BRAIN; BRAIN ISCHEMIA; EVALUATION; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; MIDDLE AGED; MONITORING; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; ROC CURVE; VASCULARIZATION;

ACUTE DISEASE; AGED; ALGORITHMS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE PROGRESSION; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; THROMBOLYTIC THERAPY;

EID: 33749254787     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl183     Document Type: Article

References (62)

1. Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Lim I, et al. Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 2006; 37: 1211-6.
2. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981; 12: 723-5.
3. Baron JC, Warach S. Imaging. Stroke 2005; 36: 196-9.
4. Bristow MS, Simon JE, Brown RA, Eliasziw M, Hill MD, Coutts SB, et al. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005; 25: 1280-7.
5. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005; 36: 1153-9.
6. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3-5 h after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-26.
7. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
8. Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME, et al. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke 2003; 34: 1681-3.
9. Davis SM, Donnan GA, Butcher KS, Parsons M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 2005; 18: 47-52.
10. Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezene Y, Philippeau F, et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci 2004; 225: 3-9.
11. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 2001; 21: 964-71.
12. Efron B. The jackknife, the bootstrap and other resampling plans. Philadelphia: Society for Industrial and Applied Mathematics; 1982.
13. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002a; 33: 79-86.
14. Fiehler J, von Bezold M, Kucinski T, Knab R, Eckert B, Wittkugel O, et al. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke 2002b; 33: 2421-5.
15. Fiehler J, Knudsen K, Kucinski T, Kidwell CS, Alger JR, Thomalla G, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004a; 35: 514-9.
16. Fiehler J, Kucinski T, Knudsen K, Rosenkranz M, Thomalla G, Weiller C, et al. Are there time-dependent differences in diffusion and perfusion within the first 6 hours after stroke onset? Stroke 2004b; 35: 2099-104.
17. Fiehler J, Knudsen K, Thomalla G, Goebell E, Rosenkranz M, Weiller C, et al. Vascular occlusion sites determine differences in lesion growth from early apparent diffusion coefficient lesion to final infarct. AJNR Am J Neuroradiol 2005; 26: 1056-61.
18. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct - relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280-4.
19. Fisher M. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke 2003; 34: 1539-46.
20. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40: 216-26.
21. Guadagno JV, Warburton EA, Aigbirhio FI, Smielewski P, Fryer TD, Harding S, et al. Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J Cereb Blood Flow Metab 2004; 24: 1249-54.
22. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-51.
23. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
24. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
25. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
26. Helgason CM. Cardioembolic stroke: topography and pathogenesis. Cerebrovasc Brain Metab Rev 1992; 4: 28-58.
27. Hermier M, Nighoghossian N, Adeleine P, Berthezene Y, Derex L, Yilmaz H, et al. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke. J Cereb Blood Flow Metab 2003; 23: 240-8.
28. Hjort N, Butcher K, Davis SM, Kidwell CS, Koroshetz WJ, Rother J, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005; 36: 388-97.
29. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-65.
30. Jacobs MA, Mitsias P, Soltanian-Zadeh H, Santhakumar S, Ghanei A, Hammond R, et al. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: Part 2. Stroke 2001; 32: 950-7.
31. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999; 353: 2036-7.
32. Japkowicz N, Stephen S. The class imbalance problem: a systematic study. Intelligent Data Analysis 2002; 6: 429-50.
33. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34: 2729-35.
34. Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B, et al. The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke 2005; 36: 2132-7.
35. Lee JM, Vo KD, An H, Celik A, Lee Y, Hsu CY, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003; 53: 227-32.
36. Lees KR, Hankey GJ, Hacke W. Design of future acute-stroke treatment trials. Lancet Neurol 2003; 2: 54-61.
37. Levine SR. Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail? J Neurol Sci 2004; 225: 1-2.
38. Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke 2005; 36: 189-92.
39. Loh PS, Butcher KS, Parsons MW, MacGregor L, Desmond PM, Tress BM, et al. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 2005; 36: 2626-31.
40. MathSoft. S-Plus 6.0 Guide to statistics. Vol. 1. Seattle, WA: Data Analysis Division; 2000.
41. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001; 356: 1293-322.
42. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, Gass A, Nolte C, Kucinski T, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35: 109-14.
43. Nighoghossian N, Hermier M, Adeleine P, Derex L, Dugor JF, Philippeau F, et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003; 34: 458-63.
44. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996; 36: 715-25.
45. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51: 28-37.
46. Rose SE, Chalk JB, Griffin MP, Janke AL, Chen F, McLachan GJ, et al. MRI based diffusion and perfusion predictive model to estimate stroke evolution. Magn Reson Imaging 2001; 19: 1043-53.
47. Rother J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6hours. Stroke 2002; 33: 2438-45.
48. Schaefer PW, Ozsunar Y, He J, Hamberg LM, Hunter GJ, Sorensen AG, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003; 24: 436-43.
49. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001; 49: 460-9.
50. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003; 34: 575-83.
51. Shimosegawa E, Hatazawa J, Ibaraki M, Toyoshima H, Suzuki A. Metabolic penumbra of acute brain infarction: a correlation with infarct growth. Ann Neurol 2005; 57: 495-504.
52. Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004; 35: 2843-7.
53. Sorensen AG, Copen WA, Østergaard L, Buonanno FS, Gonzalez RG, Rordorf G, et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999; 210: 519-27.
54. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke 2000; 31 2912-9.
55. Warach S, Baron JC. Neuroimaging. Stroke 2004; 35: 351-3.
56. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, et al. Effect of citicoline on ischemic lesions as measured by diffusionweighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 2000; 48: 713-22.
57. Wu O, Koroshetz WJ, Østergaard L, Buonanno FS, Copen WA, Gonzalez RG, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 2001; 32: 933-42.
58. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003; 50: 164-74.
59. Wu O, Christensen S, Rosa-Neto P, Hjort N, Rodell A, Dijkhuizen RM, et al. Anatomy as a parameter in multiparametic predictive algorithms [abstract]. In: Proceedings of the 12th Annual Scientific Meeting of the International Society of Magnetic Resonance for Medicine (ISMRM04). Kyoto, JP; 2004.
60. Wu O, Christensen S, Hjort N, Rosa-Neto P, Mouridsen K, Rodell A, et al. Predicting tissue infarction using acute MR imaging in stroke patients treated with thrombolytic therapy [abstract]. In: Proceedings of the 13th Annual Scientific Meeting of the International Society of Magnetic Resonance for Medicine (ISMRM05), Miami, FL; 2005a.
61. Wu O, Sumii T, Sasamata M, Rosen BR, Lo EH, Dijkhuizen RM. Effect of occlusion duration on risk of infarction in a rat embolic stroke model studied with serial MRI-based predictive algorithms [abstract]. In: Proceedings of the 13th Annual Scientific Meeting of the International Society of Magnetic Resonance for Medicine (ISMRM05). Miami, FL; 2005b.
62. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085-90.